Corporate Profile
Zentalis Pharmaceuticals is a San Diego headquartered biotech company developing investigational azenosertib, a first-in-class and potentially best-in-class WEE1 inhibitor for the treatment of Cyclin E1-positive platinum-resistant ovarian cancer.
Stock Quote
Price
Change
High
Minimum 15 minutes delayed. Source: LSEG